Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...

Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy ...

Boosting Klotho protein levels in mice improves physical and cognitive aging, offering potential for future longevity ...

Klotho Neurosciences Files $100M Mixed Shelf Klotho Neurosciences (KLTO) has filed $100,000,000 mixed shelf of: Common Stock Preferred Stock Warrants Units By Investing.com • Jul 07, 2025 ...

Klotho Neurosciences Inc Klotho Neurosciences Inc KLTO Stock XNAS Rating as of Jul 9, 2025 Download PDF More Actions ...

Review the current Klotho Neurosciences Inc (KLTO:XNAS) dividend yield and history to decide if KLTO is the best investment for you.

A high-level overview of Klotho Neurosciences, Inc. WT EXP 062129 (KLTOW) stock. View (KLTOW) real-time stock price, chart, news, analysis, analyst reviews and more.